AxoGen Announces Closing of Public Offering of Common Stock Mon, 20 Nov 2017 16:15:00 +0000 ALACHUA, Fla., Nov. 20, 2017-- AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve damage, today announced the closing of its previously announced ...
AxoGen, Inc. (Nasdaq: AXGN) to Ring The Nasdaq Stock Market Opening Bell Mon, 20 Nov 2017 15:00:00 +0000 What: AxoGen, a global leader in innovative surgical solutions for peripheral nerve regeneration and repair, will visit the Nasdaq MarketSite in Times Square. In honor of the occasion, Karen Zaderej, President, ...
AxoGen Advances its Platform for Nerve Repair at Annual Analyst and Investor Day Mon, 20 Nov 2017 13:00:00 +0000 Company Announces Expanded Application to Address Breast Reconstruction Neurotization Following Mastectomy. Company Will Continue Developing its Portfolio of Products Toward Future Applications Including ...
ETFs with exposure to AxoGen, Inc. : November 16, 2017 Thu, 16 Nov 2017 16:12:47 +0000 Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to AxoGen, Inc. Here are 5 ETFs with the largest exposure to AXGN-US. Comparing the performance and risk of AxoGen, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more
(Read more...)
November Growth Stocks To Look Out For Thu, 16 Nov 2017 16:02:30 +0000 Individual investors like stocks with a high growth potential. These companies have a strong outlook that can bring a significant upside to your portfolio, regardless of market cyclicality. If yourRead More...
AxoGen, Inc. Announces Pricing of Public Offering of Common Stock Thu, 16 Nov 2017 13:40:18 +0000 ALACHUA, Fla., Nov. 16, 2017-- AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve damage, announced today that it has priced an underwritten ...
AxoGen, Inc. Announces Proposed Public Offering of Common Stock Wed, 15 Nov 2017 21:43:24 +0000 ALACHUA, Fla., Nov. 15, 2017-- AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for the repair of peripheral nerve damage, announced today that it has commenced an ...
AxoGen, Inc. to Present at the 29th Annual Piper Jaffray Healthcare Conference Tue, 14 Nov 2017 12:00:00 +0000 ALACHUA, Fla., Nov. 14, 2017-- AxoGen, Inc., a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that Karen Zaderej, President and Chief ...
AxoGen, Inc. :AXGN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017 Fri, 03 Nov 2017 14:03:37 +0000 Categories: Yahoo FinanceGet free summary analysis AxoGen, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of AxoGen, Inc. – Thermo Fisher Scientific Inc. and Boston Scientific Corporation (TMO-US and BSX-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 16.05 million, ... Read more
(Read more...)
*Winners defined as our Top Picks that increased 20% or more within a 6-month period.
Red Letters imply that that particular criteria did not meet minimum requirements, e.g., a low GSA Rank would show it in red.
___ Red Line On Graph Shows a Trailing Stop Loss Based on Support and Resistance Levels. See how it works.
___ Blue Line On Graph Shows the 10-Week Moving Average.
___ Magenta Line On Graph Shows the 40-Week Moving Average.
Disclaimer The stock selections in our stock investing and stock trading database are not stock recommendations, but simply represent applications of a stock investing process. All materials, including our Top Stock Picks, are provided for information purposes only and should not be used or construed as an offer to sell, a solicitation of an offer to buy, or a recommendation for any security. Growth Stock Analytics, LLC is not responsible for gains/losses that may result in investing or trading in these securities. All information is believed to be obtained from reliable sources, but there is no guarantee that the information supplied is accurate, complete or timely. There is no guarantee or warranty with regard to the results obtained from its use. There is no guarantee of suitability or potential value of any particular investment or information source. You acknowledge that your requests for this information are unsolicited and shall neither constitute nor be considered investment advice. Past investing performance is not an indication of future performance results. Investing and trading in stocks is risky. Investors are encouraged to consult a registered stock broker or investment adviser before making any investing decisions. The interpretations and opinions expressed herein are solely those of Growth Stock Analytics, LLC, and not of any other individual or organization.